UnitedHealth Group Inc. (UNH) Given New $169.00 Price Target at Mizuho
UnitedHealth Group Inc. (NYSE:UNH) had its target price boosted by Mizuho from $160.00 to $169.00 in a research note issued on Wednesday. The brokerage presently has a “buy” rating on the healthcare conglomerate’s stock. Mizuho’s target price would suggest a potential upside of 17.86% from the company’s current price.
Other equities research analysts have also issued reports about the stock. Credit Suisse Group AG reissued a “buy” rating and issued a $155.00 target price (up from $148.00) on shares of UnitedHealth Group in a report on Wednesday, July 20th. Leerink Swann reissued a “buy” rating on shares of UnitedHealth Group in a report on Monday, June 27th. Citigroup Inc. increased their target price on shares of UnitedHealth Group from $148.00 to $164.00 and gave the stock a “buy” rating in a report on Wednesday, July 20th. Argus raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 target price for the company in a report on Friday, July 22nd. Finally, Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 target price for the company in a report on Friday, July 22nd. Two research analysts have rated the stock with a hold rating, twenty-four have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $155.28.
Shares of UnitedHealth Group (NYSE:UNH) opened at 143.39 on Wednesday. The company has a market capitalization of $136.56 billion, a price-to-earnings ratio of 22.44 and a beta of 0.57. The stock has a 50 day moving average of $137.12 and a 200-day moving average of $136.75. UnitedHealth Group has a one year low of $107.51 and a one year high of $144.48.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/19/unitedhealth-group-inc-unh-given-new-169-00-price-target-at-mizuho.html
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.08 by $0.09. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The firm earned $46.30 billion during the quarter, compared to analyst estimates of $46.09 billion. During the same quarter in the prior year, the firm earned $1.77 EPS. The business’s revenue for the quarter was up 11.6% compared to the same quarter last year. On average, equities analysts expect that UnitedHealth Group will post $7.90 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were issued a dividend of $0.625 per share. This represents a $2.50 annualized dividend and a dividend yield of 1.74%. The ex-dividend date was Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 39.12%.
In other news, Director Richard T. Burke sold 40,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the transaction, the director now directly owns 2,003,550 shares of the company’s stock, valued at $271,100,350.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.65% of the company’s stock.
Several institutional investors have recently bought and sold shares of the stock. Van Hulzen Asset Management LLC acquired a new position in shares of UnitedHealth Group during the second quarter worth about $104,000. Archford Capital Strategies LLC raised its position in shares of UnitedHealth Group by 669.2% in the second quarter. Archford Capital Strategies LLC now owns 800 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 696 shares during the period. Hanson McClain Inc. raised its position in shares of UnitedHealth Group by 0.4% in the second quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $126,000 after buying an additional 4 shares during the period. Howe & Rusling Inc. raised its position in shares of UnitedHealth Group by 4.5% in the second quarter. Howe & Rusling Inc. now owns 920 shares of the healthcare conglomerate’s stock worth $130,000 after buying an additional 40 shares during the period. Finally, Parkside Financial Bank & Trust raised its position in shares of UnitedHealth Group by 31.4% in the second quarter. Parkside Financial Bank & Trust now owns 996 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 238 shares during the period. 85.80% of the stock is owned by institutional investors.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.